Vimarsana
Biggest News Aggregation in the World

Page 7 - Human Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Human Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Human Data Today - Breaking & Trending Today

What happens when a $3m gene therapy is not enough - Vimarsana News

What happens when a $3m gene therapy is not enough

LOS ANGELES - Baby Ben Kutschke was diagnosed at three months with spinal muscular atrophy, a rare inherited disorder which is the leading genetic cause of death in infancy globally. It leaves children too weak to walk, talk, swallow or even breathe. So when in 2021 his parents heard about Zolgensma – a one-time therapy costing millions of dollars that...

Breakthrough in solid-state storage innovates - Vimarsana News

Breakthrough in solid-state storage innovates

Scientists have developed a novel method for storing biological materials in the form of a pill or a tablet, which dissolves in water for on-demand use. The innovation could overcome current limitations involving in the storage and handling of products derived from living cells used for a variety of health care and scientific research purposes, including pharmaceuticals and diagnostic testing tools.

Cancer drug shortage may force US doctors to ration chemotherapy - Vimarsana News

Cancer drug shortage may force US doctors to ration chemotherapy

More than a dozen cancer drugs have been in shortage in recent months, putting patients, particularly women, at risk.

2 Pharma Stocks Poised for Record-Breaking Growth - Vimarsana News

2 Pharma Stocks Poised for Record-Breaking Growth

Due to innovative drug development and increasing demand for healthcare, the pharma industry is poised to thrive in the foreseeable future. Given the significant prospects of the industry, pharma stocks...

Diversity in clinical trials has actually dropped since 2012, IQVIA finds - Vimarsana News

Diversity in clinical trials has actually dropped since 2012, IQVIA finds

Despite diversity being spoken about more than ever before, research discovers clinical trials are less representative of the US population compared to a decade prior.